The global cell culture market size is expected to reach USD 39.09 billion by 2030 and is expected to grow at a CAGR of 11.32% from 2023 to 2030, according to a new report by Grand View Research, Inc. The novel three-dimensional cell culture techniques and the growing need for them in biopharmaceutical development, vaccine production, and the rising global demand for advanced therapy medicinal products are expected to drive the market during the forecast period. The COVID-19 pandemic has increased vaccine development activities, especially in the novel mRNA and DNA vaccines space. Vaccine production at a large scale generates a high demand for vectors produced using cell culture techniques. For instance, in February 2023, SK Bioscience announced that its first cell culture-based quadrivalent influenza vaccine, SKYCellflu, was officially licensed in South America by Instituto de Salud Publica de Chile (Institute of Public Health, ISP).
Furthermore, vaccine development requires several expression analyses, quality control, and safety testing procedures, which use cell-based assays. As a result, the usage of cell culture products for such applications has witnessed high demand in recent years. In addition, with an increase in the incidence of infectious diseases, a rise in focus on prevention of disease outbreaks, and high R&D investments in vaccine technologies, vaccine production is projected to gain traction and boost market growth. Moreover, cell culture technology has witnessed significant advancements over the past few years and the technology is witnessing a rapid expansion in its scope of applications. In the field of biopharmaceuticals, researchers can now produce complex protein-based drugs in large quantities due to the ability to culture mammalian cells.
Gather more insights about the market drivers, restrains and growth of the Global cell culture market
Cell Culture Market Report Highlights
- The consumables product segment accounted for the largest share of 57.44% in 2022 due to increased R&D spending by pharmaceutical & biopharmaceutical businesses to produce advanced biopharmaceuticals, such as monoclonal antibodies, vaccines, and cell & gene therapies
- The biopharmaceutical production segment accounted for the largest share of 32.15% in 2022. The biotechnology sector is anticipated to expand, fueling demand for cell culture supplies and instruments over the forecast period
- North America dominated the market with a share of 35.90% in 2022. The large share can be attributed to the region’s well-established pharmaceutical & biotech sectors and higher adoption of technologically advanced solutions in the U.S. In addition, there is a large market for cell culture technologies in the region due to the extensive cell therapy research efforts undertaken by several universities
- Asia Pacific is projected to expand at the fastest CAGR of 13.79% over the forecast period due to the rising awareness regarding cell and gene therapies, and the rapid adoption of scientific technologies and emerging therapeutics, such as regenerative medicines and cancer immunotherapies
Browse through Grand View Research's Biotechnology Industry Research Reports.
- Spatial Proteomics Market: The global spatial proteomics market size was estimated at USD 77.6 million in 2023 and is projected to grow at a CAGR of 14.76% from 2024 to 2030.
- Gene Amplification Technologies Market: The global gene amplification technology market size was valued at USD 10.13 billion in 2023 and is projected at a compound annual growth rate (CAGR) of -0.5% from 2024 to 2030.
Cell Culture Market Segmentation
Grand view research has segmented the global cell culture market based on product, application, and region:
Cell Culture Product Outlook (Revenue, USD Million, 2018 - 2030)
- Consumables
- Sera
- Fetal Bovine Serum
- Other
- Reagents
- Albumin
- Others
- Media
- Serum-free Media
- CHO Media
- HEK 293 Media
- BHK Medium
- Vero Medium
- Other Serum-free Media
- Classical Media
- Stem Cell Culture Media
- Chemically Defined Media
- Specialty Media
- Other Cell Culture Media
- Serum-free Media
- Instruments
- Culture Systems
- Incubators
- Centrifuges
- Cryostorage Equipment
- Biosafety Equipment
- Pipetting Instruments
- Sera
Cell Culture Application Outlook (Revenue, USD Million, 2018 - 2030)
- Biopharmaceutical Production
- Monoclonal Antibodies
- Vaccines Production
- Other Therapeutic Proteins
- Drug Development
- Diagnostics
- Tissue Culture & Engineering
- Cell & Gene Therapy
- Toxicity Testing
- Other Applications
Cell Culture Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Order a free sample PDF of the Cell Culture Market Intelligence Study, published by Grand View Research.